Skip to main content

Table 4 UGT1A1 polymorphisms and clinical factors of Cox regression analysis for OS and EFS

From: Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

Variables in the model

Overall survival

Event free survival

HR (95% CI)

P value

HR (95% CI)

P value

UGT1A1 *28/− or *6/−

0.787 (0.627–0.990)

0.040

0.959 (0.700–1.313)

0.923

Risk stratification groups:

 

7.8 × 10−16

 

9.5 × 10−5

 Low vs intermediate

0.775 (0.566–1.066)

0.117

0.686 (0.493–0.953)

0.021

 High vs intermediate

2.615 (2.024–3.377)

1.9 × 10−13

1.652 (1.188–2.297)

0.003

WBC count, × 109/l

1.003 (1.001–1.005)

0.002

1.002 (1.000–1.004)

0.095

Age (years)

1.013 (1.005–1.021)

0.002

1.004 (0.995–1.013)

0.366

  1. WBC white blood cell